← back to search

Jonah R. Chan

University of California, San Francisco · US
Area of research
Developmental Neuroscience · Cellular and Molecular Neuroscience
Research interest
Research interests include Neurogenesis and neuroplasticity mechanisms, Nerve injury and regeneration, Neuroinflammation and Neurodegeneration Mechanisms, and Axon Guidance and Neuronal Signaling.
h-index
57
citations
12,046
works
129
NIH funding
primary concept
email

Recent publications

Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis.
2026cited by 2position: contributordoi
Next-gen micropillars for investigating oligodendrocyte myelination.
2026cited by 0position: contributordoi
Enhancing myelination in a high-poxic environment
Neuron 2026cited by 0position: contributordoi
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis
Nature Medicine 2025cited by 9position: middledoi
Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination.
2025cited by 8position: contributordoi
Oligodendrocytes and myelin limit neuronal plasticity in visual cortex
Nature 2024cited by 57position: lastdoi
Oligodendrocytes and myelin limit neuronal plasticity in visual cortex.
2024cited by 46position: contributordoi
Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis
Proceedings of the National Academy of Sciences 2024cited by 32position: lastdoi
Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis
Cell Reports Medicine 2024cited by 23position: middledoi
Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis.
2024cited by 18position: contributordoi
Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.
2024cited by 17position: contributordoi
Minimum effective dose of clemastine in a mouse model of preterm white matter injury
Pediatric Research 2024cited by 7position: middledoi
Minimum effective dose of clemastine in a mouse model of preterm white matter injury.
2024cited by 6position: contributordoi
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy.
2024cited by 2position: contributordoi
Minimum Effective Dose of Clemastine in a Mouse Model of Preterm White Matter Injury
2024cited by 2position: contributordoi
Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
2024cited by 0position: contributordoi
MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial
Proceedings of the National Academy of Sciences 2023cited by 54position: middledoi
MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial.
2023cited by 41position: contributordoi
Insights into the mechanism of oligodendrocyte protection and remyelination enhancement by the integrated stress response.
2023cited by 13position: contributordoi
Remyelination by preexisting oligodendrocytes: Glass half full or half empty?
2023cited by 4position: contributordoi
Insights into the mechanism of oligodendrocyte protection and remyelination enhancement by the integrated stress response
2023cited by 0position: contributordoi
Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy
Brain 2022cited by 65position: middledoi
Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy.
2022cited by 57position: contributordoi
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis.
2022cited by 26position: contributordoi
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial.
2022cited by 9position: contributordoi
Motor learning revamps the myelin landscape.
2022cited by 4position: contributordoi
Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer’s disease
Neuron 2021cited by 329position: middledoi
Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer's disease.
2021cited by 272position: contributordoi
Building a (w)rapport between neurons and oligodendroglia: Reciprocal interactions underlying adaptive myelination
Neuron 2021cited by 77position: lastdoi
Building a (w)rapport between neurons and oligodendroglia: Reciprocal interactions underlying adaptive myelination.
2021cited by 66position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 26 papers (2019–2026)Feng Mei · Army Medical University12 papers (2013–2021)Lan Xiao · Kunming University of Science and Technology10 papers (2013–2021)Ari Green · University of California, San Francisco10 papers (2014–2025)Sonia R. Mayoral · University of California, San Francisco9 papers (2014–2020)Stephanie Redmond · University of California, San Francisco7 papers (2012–2016)Stephen P.J. Fancy · University of California, San Francisco7 papers (2014–2021)Jianqin Niu · Army Medical University7 papers (2013–2021)Yun‐An Shen · Sunesis (United States)6 papers (2014–2019) · 5 papers (2016–2024)Yanan Chen · South China Agricultural University5 papers (2020–2023)Brian Popko · University of Chicago5 papers (2020–2023)Wendy Xin · Washington University in St. Louis5 papers (2020–2024)W. John Boscardin · Lee University4 papers (2017–2026)Bruce Cree · California State University, Bakersfield4 papers (2017–2026)Wendy Xin · Washington University in St. Louis4 papers (2020–2024)Fei Wang · Second Military Medical University4 papers (2016–2021)Sergio E. Baranzini · University of Cambridge4 papers (2019–2026)Sergio E. Baranzini · Institute of Bioinformatics4 papers (2014–2025)Christian Cordano · Ospedale Policlinico San Martino3 papers (2022–2025)